- Travere Therapeutics (TVTX, Financial) has granted inducement equity awards to six new employees.
- The RSUs cover 31,100 shares of common stock, with a vesting schedule of four years.
- Grants issued under Nasdaq Listing Rule 5635(c)(4) to attract new hires.
Travere Therapeutics, Inc. (TVTX) announced that on April 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity awards to six new employees. The grants consist of restricted stock units (RSUs) covering an aggregate of 31,100 shares of Travere's common stock. These awards were made outside the company’s 2018 Equity Incentive Plan but remain subject to its terms. The inducement grants are issued in compliance with Nasdaq Listing Rule 5635(c)(4), serving as key incentives to attract new talent to the organization.
The RSUs granted by Travere (TVTX, Financial) feature a vesting schedule that spans four years. Under this schedule, 25% of the shares will vest annually on the anniversary of the grant date. This vesting is contingent upon the continuous employment of the recipients with Travere Therapeutics.
